NEED ORDER STATUS? TEXT US AT 858-264-2082
Order

Total Tears®

Total Tears®

Eye drops for ocular surface conditions

Preservative-Free Topical Drops

Total Tears® offers topical compounded formulations as an alternative treatment for your patients.

Klarity-C cyclosporine 0.1% eyedrop, topical eye drop, ocular surface conditions

Klarity-C Drops® (Cyclosporine 0.1% ophthalmic emulsion PF) are now available for $59 per month.**

For a limited time, start your patients today for as low as $1 for their first month*. No prior authorizations or coupon eligibility hassle.

Have questions? Click here to request more information or enter our CHAT to get immediate assistance from a specialist.

 

Our Total Tears Formulations**

  • Klarity Drops® (Glycerin and dextran based vehicle ophthalmic solution PF)
  • Klarity-A Drops® (azithromycin 1% ophthalmic solution PF)
  • Klarity-C Drops® (cyclosporine 0.1% ophthalmic emulsion PF)
  • Klarity-L Drops ®(loteprednol etabonate 0.5% ophthalmic suspension PF)
  • Klarity-CL Drops (cyclosporine 0.1%/loteprednol etabonate 0.2% ophthalmic suspension PF) | NEW to ImprimisRx August 2021

Affordable Prices without Insurance or Coupons

Klarity-C Cyclosporine Eye Drops, Klarity-A Azithromycin EyeDrops, Klarity Tear Eye Drops, Klarity-L Loteprednol Etabonate 0.5% EyeDrops, Klarity-CL Cyclosporine 0.1% and Loteprednol Etabonate 0.2% Eye Drops, ocular surface condition eyedrops

Click on Image to Zoom

HOW TO ORDER

Get your patients started today with 3 easy ways to order.

Click here to request more information or enter our CHAT to get immediate assistance from a specialist.

*Only available on new prescriptions. Cannot be combined with other discounts. Automatic refill set up is required. Months supply can vary based on the dosing regimen prescribed by the doctor. Full details of program eligibility are available by contacting ImprimisRx.

**For professional use only. ImprimisRx® specializes in customizing medications to meet unique patient and practitioner needs. ImprimisRx® dispenses only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.